We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Mr
Joseph Brindaban
Selvanayagam
+44 (0)1865 221867
joseph.selvanayagam@cardiov.ox.ac.uk
CABG surgery
This information is provided directly by researchers and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information.
Not provided at time of registration
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
2004 Results article in http://www.ncbi.nlm.nih.gov/pubmed/14732755 results
You can take part if:
You may not be able to take part if:
1. Age greater than 75 years (ten patients)2. Ppre-existing Left Ventricular (LV) dysfunction (ejection fraction less than 20% by echocardiogram; four patients)3. Involvement in other clinical trials (ten patients)4. Typical MRI contraindications (e.g. pacemaker, severe claustrophobia etc.; total of nine patients)5. Baseline creatinine more than 200 µmol/L (two patients)
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
This information has not yet been provided by the study team. You'll have an opportunity to discuss any risks and benefits that may be associated with this study prior to consenting to taking part.
Mr
Joseph Brindaban
Selvanayagam
+44 (0)1865 221867
joseph.selvanayagam@cardiov.ox.ac.uk
The study is sponsored by University of Oxford (UK) and funded by Wellcome Trust (UK) (grant ref: 066216).
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
